RS51495B - Indolizini kao inhibitori protein kinaza - Google Patents

Indolizini kao inhibitori protein kinaza

Info

Publication number
RS51495B
RS51495B YUP-184/04A YUP18404A RS51495B RS 51495 B RS51495 B RS 51495B YU P18404 A YUP18404 A YU P18404A RS 51495 B RS51495 B RS 51495B
Authority
RS
Serbia
Prior art keywords
heteroaryl
aryl
alkyl
heterocycloalkyl
cycloalkyl
Prior art date
Application number
YUP-184/04A
Other languages
English (en)
Inventor
Andrew James Ratcliffe
Rodger John Aitchison Walsh
Tahir Nadeem Majid
Sukanthini Thurairatnam
Shelly Amendola
David John Aldous
John Edward Souness
Conception Nemecek
Sylvie Wentzler
Corinne Venot
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Priority to MEP-165/08A priority Critical patent/MEP16508A/xx
Publication of YU18404A publication Critical patent/YU18404A/sh
Publication of RS51495B publication Critical patent/RS51495B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YUP-184/04A 2001-09-19 2002-09-17 Indolizini kao inhibitori protein kinaza RS51495B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-165/08A MEP16508A (en) 2001-09-19 2002-09-17 Chemical compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0122560.6A GB0122560D0 (en) 2001-09-19 2001-09-19 Chemical compounds
US35586002P 2002-02-11 2002-02-11

Publications (2)

Publication Number Publication Date
YU18404A YU18404A (sh) 2006-08-17
RS51495B true RS51495B (sr) 2011-04-30

Family

ID=9922322

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-184/04A RS51495B (sr) 2001-09-19 2002-09-17 Indolizini kao inhibitori protein kinaza

Country Status (6)

Country Link
US (1) US20070238734A1 (sr)
KR (1) KR100927545B1 (sr)
GB (1) GB0122560D0 (sr)
ME (1) MEP16508A (sr)
RS (1) RS51495B (sr)
ZA (1) ZA200402183B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004282219C1 (en) 2003-10-15 2009-12-17 Osi Pharmaceuticals, Inc. Imidazo [1, 5 - a] pyrazine tyrosine kinase inhibitors
EP2168968B1 (en) 2004-04-02 2017-08-23 OSI Pharmaceuticals, LLC 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
MY139689A (en) 2004-07-20 2009-10-30 Osi Pharm Inc Imidazotriazines as protein kinase inhibitors
US7566721B2 (en) * 2005-08-08 2009-07-28 Osi Pharmaceuticals, Inc. Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
AR057960A1 (es) * 2005-12-02 2007-12-26 Osi Pharm Inc Inhibidores de proteina quinasa biciclicos
US8575164B2 (en) * 2005-12-19 2013-11-05 OSI Pharmaceuticals, LLC Combination cancer therapy
EP2250173A1 (en) * 2008-01-18 2010-11-17 OSI Pharmaceuticals, Inc. Imidazopyrazinol derivatives for the treatment of cancers
JP2011520970A (ja) * 2008-05-19 2011-07-21 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド 置換されたイミダゾピラジン類およびイミダゾトリアジン類
CA2752826A1 (en) 2009-04-20 2010-10-28 OSI Pharmaceuticals, LLC Preparation of c-pyrazine-methylamines
EP2427192A1 (en) * 2009-05-07 2012-03-14 OSI Pharmaceuticals, LLC Use of osi-906 for treating adrenocortical carcinoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4696776B2 (ja) 2005-08-17 2011-06-08 ソニー株式会社 音声処理装置及びマイク装置

Also Published As

Publication number Publication date
KR20040035841A (ko) 2004-04-29
ZA200402183B (en) 2005-05-09
GB0122560D0 (en) 2001-11-07
MEP16508A (en) 2010-06-10
YU18404A (sh) 2006-08-17
KR100927545B1 (ko) 2009-11-20
US20070238734A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
AR036106A1 (es) Compuestos azaindoles inhibidores de quinasa selectivos, composiciones farmaceuticas y el uso de dicha composicion para la fabricacion de un medicamento
AR066460A2 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
HRP20020926B1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
CY1114213T1 (el) Μεθοδοι απομονωσης κρυσταλλικης μορφης ι της 5-αζακυτιδινης
ATE389635T1 (de) Pharmazeutisch wirksame piperidinderivate
AR053652A1 (es) Derivados de indol como inhibidores de proteina quinasas. composiciones farmaceuticas
CO5640127A2 (es) Compuestos quimicos y composiciones farmaqceuticas a base de indolizinas
RS52953B (sr) Piridopirimidinonski inhibitori pi3 kalfa
HUP0400326A2 (hu) Orexin receptor antagonistákként alkalmazható ciklikus N-(aril-karbonil)-amin-származékok és ezeket tartalmazó gyógyszerkészítmények
AR077267A1 (es) Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
AR080596A1 (es) Compuestos alquilamido y composiciones farmaceuticas
DK1261602T3 (da) Imidazol-2-carboxamidderivater som Raf-kinaseinhibitorer
HRP20021023B1 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
BR0014641A (pt) Derivados de sulfonamida farmaceuticamente ativa, uso de um derivado de sulfonamida, uso de sulfonamidas, composto farmacêutico contendo pelo menos um derivado de sulfonamida e processo para preparação de um derivado de sulfonamida
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
AR049346A1 (es) 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas
RS51495B (sr) Indolizini kao inhibitori protein kinaza
AR064657A1 (es) 8- alquinilxantinas y derivados
AR020165A1 (es) Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos
AR038404A1 (es) Derivados de nicotinamida utiles como inhibidores de pde4, procedimiento para la preparacion del compuesto y composicion farmaceutica que lo incluye
CO5650231A2 (es) Derivados de 1-(alquilaminoalquil-pirrolidin-/piperidinil)-2,2-difenilacetamida como antagonistas del receptor muscarinico, su procedimiento de sintesis y composiciones farmaceuticas que los contienen
FR2948940B1 (fr) Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY29739A1 (es) Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones
PA8589801A1 (es) Aminoalcoxiindoles
AR068111A1 (es) Compuesto de pirazina y piperidina piperazinil sustituida, composicion farmaceutica que lo comprende y su uso para preparar un medicamento